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Protein modified gold nanoparticle based immunoassays are the basis of many novel
detection techniques. There are many groups working on novel immunoassays but there is still
much to understand about how many proteins are attached onto each nanoparticle and much to
improve on immobilization methods. This thesis work is devoted to improving techniques for the
quantification of protein immobilized on the gold nanoparticle and development of a novel
approach to immobilize protein independent of pH.
The ability to evaluate antibody immobilization onto gold nanoparticles is critical for
assessing coupling chemistry and optimizing the sensitivity of nanoparticle-enabled biosensors.
Herein, we developed a fluorescence-based method for directly quantifying antibodies bound
onto gold nanoparticles. Antibody-modified gold nanoparticles were treated with KI/I2 etchant to
dissolve the gold nanoparticles. A desalting spin column was used to recover the antibody
released from the nanoparticles, and NanoOrange, a fluorescent dye, was used to quantify the
antibody. We determined 309 ± 93 antibodies adsorb onto each 60 nm gold nanoparticle (2.6 ×
1010 NP/mL), which is consistent with a fully adsorbed monolayer based on the footprint of an
IgG molecule. Moreover, the increase in hydrodynamic diameter of the conjugated nanoparticle
(76 nm) compared to that of the unconjugated nanoparticle (62 nm) confirmed that multilayers
did not form. A more conventional method of indirectly quantifying the adsorbed antibody by

analysis of the supernatant overestimated the antibody surface coverage (660 ± 87 antibodies per
nanoparticle); thus, we propose the method described herein as a more accurate alternative to the
conventional approach.
The immobilization of antibody onto gold nanoparticles is important for many novel
nanoparticle based immunoassays. Current methods of immobilization are limited by the
inability to immobilize antibody onto gold nanoparticles over a range of pH values. Direct
adsorption requires the pH to be slightly higher than the isoelectric point of the antibody and
covalent attachment via bifunctional crosslinking chemistry molecules requires a specific pH as
well. This is an issue when working with multiple antibodies at once for multiplex detection. In
this thesis, we present a new method of immobilization by which the antibody is modified via a
molecule with a N-hydroxysuccinimidyl ester group, then adsorbed onto a gold nanoparticle. We
demonstrate that modification of antibodies allows for adsorption onto gold nanoparticles
independent of pH. Furthermore, we show that this modification method is applicable to multiple
antibodies. Finally, we show that these modified antibodies are active and comparable to
conventional assays.
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Quantitation, Homogeneous Immunoassay, Fluorescence, DLS, NTA, Nanoparticle Aggregation
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CHAPTER I
INTRODUCTION
Gold Nanoparticles (AuNP) for In-Vitro Diagnostics
Gold nanoparticles (AuNPs) conjugated to various biomolecules utilized for diagnostic
purposes have been a large area of interest in recent years. AuNPs are useful because they have
unique physical and chemical properties that can be exploited for many enhanced chemical and
biological detection techniques.1-3 The surface chemistry of gold nanoparticles is readily tuned;
thus, detection platforms utilize a variety of biomolecules that can be conjugated to AuNPs such
as proteins, nucleic acids, and polysaccharides to facilitate the detection of a variety of
analytes.2,3 Several detection platforms capitalize on the unique optical properties of gold
nanoparticles for signal transduction. Endo and co-workers used localized surface plasmon
resonance (LSPR) to develop a nanoparticle-based chip capable of detecting multiple antibodies
at once at a 100 pg/mL detection limit.4 Elghanian et al. took advantage of nucleotide modified
gold nanoparticles and developed a sensitive colorimetric platform for detection of
polynucleotides with ~10 femtomolar detection limits.5 Many groups have used dynamic light
scattering (DLS), including the Driskell lab for the detection of influenza and the Huo group for
the detection of cancer biomarkers, as a simple, one-step, and high throughput technique.6-9
Surface enhanced Raman spectroscopy (SERS) is a widely known technique in which modified
gold nanoparticles are used for the detection of many analytess at once.10-13 Many diagnostic
techniques employing metallic nanoparticles for the detection of specific biomarkers entail
proteins to be adsorbed onto the surface of the nanoparticle due to the high specificity and
selectivity of proteins. Antibody-antigen interactions are highly exploited in many of these
detection techniques.11 Consequently, conjugation is fundamental to the stability, functionality,
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and overall success of AuNP based detection platforms. Similarly, efficiency of the conjugation
chemistry, i.e., the number of adsorbed proteins, is imperative to the optimization of novel
immunosensors.
Anatomy of Immunoglobin G (IgG)
It is vital to know the structure and function of the protein when developing an assay. The
normal function of IgG antibodies is to bind to a specific target (antigen). IgGs are in the body to
recognize many foreign objects such as proteins, bacteria, and viruses that are introduced into the
body, and IgG is produced by b-cells as a secondary immune response to these foreign objects.14
IgG is a protein dimer made up of two main portions: the heavy chain and the light chain.
The heavy chain is made up of three domains in the constant region CH1, CH2, and CH3 and one
variable region VH; each of these domains are approximately 110 amino acids in length.14 The
light chain is made up of two domains, a constant portion denoted as CL and a variable portion
VL; these domains are approximately 110 amino acids in length as well.14 These can be further
broken down into the Fc portion that consists of the CH2 and CH3 subunits and the Fab portion
that consist of the CH1, VH, CL, and VL subunits.14 The differences in the CH domains typically
affect the flexibility and affinity with antigens.15 Figure 1 is a cartoon depiction of a typical IgG
molecule.
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Figure 1. General structure of an IgG with the heavy chain colored in blue and the light
chain colored in green. The darker colors indicate the variable regions of the light and heavy
chains where the binding sites are located.

The Fc and Fab regions are held together by disulfide bonds; this is very important to the
structure of the IgG protein.15 In IgG, each subunit has at least one interchain disulfide bond and
one holding the Fab heavy and light chains together. Also there are two disulfide bonds
connecting the Fc portion to the Fab portion.14
The binding sites are located in the variable regions (VH and VL) on the Fab portion of
the antibody with two identical binding sites per IgG molecule. On the Fc portion of the antibody
there are a few N-linked glycans bonded via N-C bond on each of the CH2 domains; these
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carbohydrates help with affinity toward binding to Fc receptors on the surface of cells such as Tcells.14 While the function is largely unknown, it has been experimentally shown that without
these glycans the Fc receptors do not bind with the same affinity.14
Immobilization of Protein onto AuNPs
There are a variety of methods to immobilize protein onto AuNPs; however, they can be
classified into two types of immobilization, non-covalent and covalent. Non-covalent attachment
is simply the direct adsorption of protein onto gold nanoparticles. This attachment occurs
through electrostatic and hydrophobic interactions between the protein and AuNP.16,17 Direct
adsorption has limitations due to the attachment requiring the pH of the solution to be specific
for each protein. It has been shown that for optimal binding the solution pH must be slightly
higher than the isoelectric point (pI) of the antibody.18 Further limitations of direct adsorption
include nonspecific adsorption and random orientation of the protein onto the surface of the gold
nanoparticle.
In an effort to overcome the limitations of direct adsorption, several methods have been
developed by which proteins can be covalently attached onto the surface of gold nanoparticles.
Carbohydrates, if present on the protein, can be used for immobilization; however, this is a laborintensive method which requires several steps and is time consuming.19 One of the most common
covalent immobilization strategies is the use of N-hydroxysuccinimidyl ester molecules for
cross-linking proteins onto the surface of a gold nanoparticle.20 This is performed by first
covalently adding an N-hydroxysuccimidyl ester molecule onto the surface of the gold
nanoparticle, followed by the addition of the desired protein. The linking process has been
thought to be performed by creating an amide bond through a terminal amine group presented by
a lysine; however, recently it has been shown that hydrolysis of the ester groups occurs faster
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than aminolysis of the amine to form an amide bond.21 Proteins A and G can also be used to
immobilize antibody onto the gold nanoparticle for directed immobilization.22 These binding
proteins have an affinity to the Fc region of IgG making them an ideal method of non-covalent
conjugation; however, this binding occurs reversibly. Also, proteins A and G do not have the
same affinity for all antibodies; thus, they cannot be applied as universal immobilization
strategies. For example, protein A strongly binds human IgG but weakly binds to goat IgG.23
Characterization of AuNP-Protein Conjugates
Coagulation Test for AuNP-Protein Stability
When developing a new nanosensor based on proteins conjugated onto gold nanoparticles
it is important to confirm that the protein of interest attaches onto the nanoparticle. Additionally,
it is necessary to establish that the protein-gold nanoparticle conjugate is stable under saline
conditions. The necessity of a saline environment is important for the protein to function
properly due to native physiological conditions of the protein. These two conditions can be
evaluated with a simple coagulation study of the gold nanoparticle-protein conjugate of
interest.24 A coagulation test is the addition of NaCl into the solution of a gold nanoparticleprotein conjugate. Typically gold nanoparticles are citrate reduced; thus, the negatively charged
citrate surrounds the positively charged gold nanoparticle forming an electrical double layer to
stabilize AuNPs in solution.25 Since NaCl is highly soluble in water, the Na+ and Cl- ions will
disrupt the electric double layer and cause AuNPs to aggregate. If a protein adsorbs onto the gold
nanoparticles surface it will displace the citrate group leaving a stable conjugate (i.e. new
electrical double layer); however, in the absence of full protein coverage this electrical double
layer collapses causing aggregation. This aggregation, if significant, can be detected by the
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naked eye. The native color of a 60 nm gold nanoparticle solution is red, but after aggregation it
changes to blue-purple and even colorless if the aggregates are large enough to sediment.
Light Scattering Techniques for AuNP-Protein Conjugation and Aggregate Detection
Dynamic Light Scattering
Dynamic light scattering (DLS) is a technique that is capable measuring the
hydrodynamic diameter (DH) of gold nanoparticles and AuNP-protein conjugates. This allows
for the detection of aggregates that cannot be seen by the naked eye and allows for the
monitoring of protein conjugation onto AuNPs. DLS is measured using a 532 nm laser and
illuminating the sample. The sample (particle) scatters the light which is then detected. Because
the particle has Brownian motion, over time the intensity of the scattered light fluctuates which is
measured by the detector (Figure 2). This size measurement is obtained from the detection of
light intensity fluctuations.

Figure 2. Schematic of how intensity fluctuations are related to the Brownian motion of a
particle in DLS. A) Intensity fluctuations of a large particle. B) Intensity fluctuations of a small
particle. Figure adapted from https://en.wikipedia.org/wiki/File:DLS.svg.26
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If the particle is large, it will move slower thus the fluctuations in intensity over time will
be broad as illustrated in Figure 2A. If the particle analyzed is small, it will be moving faster
through solutions giving more fluctuation over time shown in Figure 2B. These fluctuations are
fit to the auto correlation function to calculate D, which can be correlated to DH via the StokesEinstein equation (Equation 1)

𝐷𝐻 =

𝑘𝑇
3𝜋𝜂𝐷

(1)

where DH is the hydrodynamic diameter, k is the Boltzmann constant, T is temperature in Kelvin,
η is the viscosity of the solution, and D is the translational diffusion coefficient.27 DLS is a high
throughput technique that is valuable for monitoring protein-AuNP interactions.
Nanoparticle Tracking Analysis
Another method of aggregate detection and protein conjugation onto AuNPs is
nanoparticle tracking analysis (NTA). While NTA also measures the DH of a gold nanoparticleprotein conjugate through the detection of scattering, it performs this by illuminating the sample
with a 532 nm laser and measuring the scattered light by capturing a video via microscope
focusing shown in Figure 3.28
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Figure 3. A schematic of the NTA sample stage. Adapted from (B. Carr et al.) 28

The captured video is then analyzed with NanoSight software that correlates the particles’
Brownian motion to the DH utilizing the Stokes-Einstein equation (Equation 1). NTA calculates
the DH by tracking individual particles in the NanoSight software; this allows it to calculate the
absolute number of particles analyzed giving rise to the concentration of particles in solution.
Similar to DLS, NTA is a useful technique for the detection of antibody binding onto gold
nanoparticles by measuring a shift in the hydrodynamic diameter of the nanoparticles before and
after antibody conjugation.
Protein Quantitation Methods for Protein-Conjugated AuNPs
When developing an immunosensor by immobilizing protein onto AuNPs, a method for
the accurate quantitation of protein surface coverage is critical for the optimization of assay
performance. Direct quantitative methods of measuring protein immobilized on the surface of
AuNPs is challenging, regardless of this being fundamental to the development of novel AuNP
based assays. Supernatant analysis of the excess protein after incubation with AuNPs by
8

modified Bradford or BCA total protein assays are the most common methods of approaching
this problem.29,30 For example Vertegel et al. determined there are 120 lysozyme molecules on a
20 nm silica nanoparticle using supernatant analysis with a BCA total protein assay.30 These
methods, however, are used to infer the amount of protein adsorbed onto AuNPs and are not a
direct measurement. Pollitt et al. measured shifts in surface plasmon resonance due to protein
adsorption as a tool to quantify the amount of antibody directly adsorbed onto a gold
nanoparticle corresponding to 80 antibody molecules per 50 nm particle.31 This is a direct
method of analysis; however, it requires accurate knowledge of the refractive index at the gold
nanoparticle surface. This is challenging since the refractive index is dependent on coverage,
orientation, and water content, all of which are variable.31-33 Other techniques such as dynamic
light scattering (DLS)32,34,35 and nanoparticle tracking analysis (NTA)7,32 are used to monitor
protein adsorption as a function of increasing protein-AuNP diameter, but they measure the
surface coverage of protein and do not directly quantify the protein.
Immunoassays Utilized in the Driskell Lab
Currently in the Driskell lab group we employ two methods for simple, fast, and specific
detection of proteins: dynamic light scattering (DLS) and surface enhanced Raman spectroscopy
(SERS).
The first method of detection used in our lab for immunoassays is a dynamic light
scattering (DLS) assay. DLS measures the hydrodynamic diameter of a nanoparticle based on the
Brownian motion of the nanoparticle.27 This assay is a simple one-step method that is fast,
sensitive, and accurate. In this method, antibody is immobilized onto a gold nanoparticle. When
the antibody-modified gold nanoparticles are introduced to antigen they bind around it forming
large aggregates as illustrated in Figure 4A.
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Antigen

Figure 4. A) Schematic of antibody modified AuNPs before and after aggregation. B) Typical
histogram observed with DLS on a negative control (PBS) and an antigen sample (5 ng/mL) with
relative abundance vs hydrodynamic diameter (nm).

Prior to the addition of antigen, or in the case of a negative sample, a uniform narrow
peak is observed indicating that the conjugates are not aggregated (Figure 4B). Upon mixing
with antigen, the antibody modified gold nanoparticles aggregate and a large size increase is
observed in the DLS histogram (Figure 4). Our group has previously demonstrated this DLS
assay can be performed in 1 hour and provides a better detection limit than traditional ELISAs
which require 24 hours to complete.6
Surface-enhanced Raman spectroscopy is a two-step immunoassay with gold
nanoparticles that are co-functionalized with an antibody and a Raman reporter. These
functionalized gold nanoparticles are commonly referred to as extrinsic Raman labels (ERLs)
(Figure 5A). Similar to the DLS assay described above, this assay takes advantage of the high
specificity of antibody-antigen interactions, and ERLs form large aggregates when antigen is
introduced. These aggregates are captured on a 0.2 µm polycarbonate tract etch (PCTE) filter
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while the remaining unaggregated ERLs flow through the filter to waste (Figure 5B).11 SERS is
measured on the filter surface to determine the quantity of analyte. This method is fast, simple,
and has the capability for the simultaneous detection of multiple analytes. In a multiplexed SERS
assay, multiple ERLs are prepared, each with a different antibody and Raman reporter that has a
unique spectrum for easy and fast identification.

A
)

B
)

Figure 5. Schematic of ERL preparation and a SERS immunoassay. A) ERL preparation and
aggregation. B) Typical SERS assay with the aggregates sticking on the filter while nonaggregated ERLs flow through the filter to waste.11

Central to both detection platforms, protein is immobilized onto the surface of gold
nanoparticles. The previous work in the Driskell lab has established proof of principle for these
two novel assays;6,11 however, better characterization techniques of these conjugates are needed.
For example, a long standing question is the absolute number of antibody adsorbed onto each
nanoparticle. Moreover, greater efforts on conjugate chemistry are needed, particularly for the
development of multiplexed assays. We have found that each antibody requires unique solution
11

conditions to remain stable.6 Thus, the development of a synthetic approach to yield stable
conjugates, independent of antibody, that can co-exist in a single solution is needed.
Thesis Objective
Based on previous work done in the Driskell Lab as well as literature research, the focus
of this thesis is to develop a method for the direct quantitation of protein adsorbed onto gold
nanoparticles and to develop a technique to stabilize multiple unique Ab-AuNP conjugates in the
same suspension.
Research Overview
A fundamental aspect of preparing protein conjugated AuNPs for immunoassays is the
ability to quantify the amount of antibody on the surface of the gold nanoparticle. This is a key
element for the determination of the quality of the assay and for assay optimization. While there
are methods of quantifying antibody such as supernatant analysis which can be used to infer the
amount of protein adsorbed via modified Bradford assays or BCA total protein assays,29,30 these
methods are indirect and do not measure the exact amount of protein adsorbed onto the AuNP.
Therefore, we developed and evaluated a novel scheme (Figure 6) to isolate and detect the
antibodies adsorbed onto the AuNP as an improved method to accurately and quantitatively
determine the number of antibodies per AuNP.
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Figure 6. An overview of the protein quantification process.

Protein modification of gold nanoparticles is essential for many novel nanoparticle based
immunosensors including those currently under development in the Driskell lab. Procedures can
have many steps or be as simple as directly adsorbing protein onto AuNPs; however, most
procedures have one common drawback, the inability of the immobilization process to produce
stable AuNP-protein conjugates under a range of pH values. This is problematic because all
proteins have a specific pH at which they can be immobilized which is slightly more basic than
the isoelectric point of the protein.18
Conventional methods of immobilization are performed by direct adsorption presented in
Figure 7A or with a bifunctional crosslinking molecule such as 3, 3’-dithiobis(sulfosuccinimidyl
propionate) (DTSSP) shown in Figure 7B.
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Figure 7. An illustration of the immobilization methods. A) Direct adsorption. B)
Immobilization utilizing DTSSP as a bifunctional crosslinking molecule. C) Method of
immobilization by attaching DTSSP to the antibody before adsorbing onto the AuNPs. D)
Method of immobilization by attaching to acrylic acid (NHS) onto the antibody before adsorbing
onto the AuNPs.

Recent studies suggest that hydrolysis occurs faster than aminolysis; thus, conventional
methods of immobilization using a bifunctional crosslinking molecule do not produce stable
antibody-AuNP conjugates over a range of pH values. If bifunctional crosslinking is attempted
via the addition of DTSSP on the nanoparticle surface then it requires the antibody to diffuse
through the solution to come into contact with the DTSSP before hydrolysis occurs of the
terminal ester group on the DTSSP molecule (Figure 7B). In this work, we used the bifunctional
crosslinking molecule (DTSSP) that is conventionally used; however, we modified the antibody
before the introduction of AuNPs (Figure 7C). This modification allowed for the concentration
and diffusion rate of the DTSSP molecule to facilitate aminolysis with the terminal amine of
lysine before hydrolysis of the hydroxysuccimidyl ester group on DTSSP. Finally we used
acrylic acid (NHS) (Figure 7D) to determine if the terminal sulfur group facilitates binding to
AuNPs.
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CHAPTER II
A FLUORESCENCE-BASED METHOD TO DIRECTLY QUANTIFY ANTIBODY
IMMOBILIZED ON GOLD NANOPARTICLES
This Study has been published in the journal Analyst as Seth L. Filbrun and Jeremy D. Driskell.
A fluorescence-Based Method to Directly Quantify Antibodies Immobilized on Gold
Nanoparticles. Analyst. 2016, 141, 3851-3857. 36
Introduction
Protein-modified gold nanoparticles are central to many novel and emerging biosensing
technologies.37-40 The sensitivity of these nanoparticle-based methods is often governed by the
coupling chemistry between the nanoparticle and protein; an interaction which controls the
surface coverage and protein orientation.3,41-43 In order to optimize the surface coupling
chemistry and increase assay performance, a method for the accurate quantitation of surface
coverage is critical. Such a method will enable conditions for maximum protein coverage to be
identified, and facilitate proper assessment of novel coupling chemistry by ensuring enhanced
assay performance is due to improved orientation rather than surface coverage. In addition, an
accurate method to quantify surface coverage is needed to assess the reproducibility of
nanoparticle preparations which can influence assay quality control.43
Direct quantitative methods to measure surface coverage of proteins conjugated onto gold
nanoparticles remains challenging, despite this being of fundamental importance to nanoparticlebased applications. Most commonly, analysis of excess protein in the supernatant after
incubation with the nanoparticle suspension is used to infer the quantity of adsorbed protein.
Protein concentrations are often low; but, modified Bradford and BCA total protein assays are
typically capable of detecting these low concentrations.30,44 Alternatively, fluorescently labelled
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proteins can be used and low concentrations of excess proteins in solution can be measured with
fluorescence.45,46 This requires modification of the protein by fluorophore functionalization,
which can interfere with the coupling chemistry or affect the protein adsorption characteristics.
These approaches are indirect measurements of the adsorbed protein and assume no loss of
protein due to adsorption to container walls, e.g., centrifuge tube. Nevertheless, this approach
results in a measure of the absolute number of immobilized antibodies per nanoparticle.
More recently, antibody adsorption has been quantified by measuring shifts in the surface
plasmon resonances due to changes in the local refractive index caused by protein adsorption.31
While this is a more direct analysis of the adsorbed proteins, it requires accurate knowledge of
the refractive index at the nanoparticle surface. This is quite challenging considering the
refractive index depends on coverage, orientation, and water content, none of which are
constant.47-49
A number of additional techniques have been evaluated to measure the surface
concentration relative to saturation, but do not give an absolute quantitation of adsorbed protein.
Dynamic light scattering (DLS)7,47,50,51 and nanoparticle tracking analysis (NTA)7,47 measure an
increase in hydrodynamic diameter upon protein adsorption. The increase in diameter is
correlated with relative surface coverage. Similarly, zeta potential,52,53 analytical
ultracentrifugation,54 and electrospray differential mobility analysis55 have all been used to
measure relative surface coverage.
In this chapter we present a fluorescence-based method for directly quantifying the
absolute number of antibodies adsorbed onto gold nanoparticles. The detection of adsorbed
antibodies is accomplished by dissolving the gold nanoparticle and using a fluorescent dye,
NanoOrange,56,57 to quantify the protein previously adsorbed onto the nanoparticles. A
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fluorescent dye, such as NanoOrange, was selected to quantify the protein because fluorescence
typically provides a lower detection limit and larger dynamic range than absorbance based
protein quantification strategies. NanoOrange was specifically selected as the fluorescent dye as
it has previously been demonstrated to broadly react with many proteins and has been wellcharacterized with respect to the effects of contaminants on assay performance.56 We
demonstrate that this novel method is more accurate than the commonly used indirect method
based on mass difference in the added and excess antibody remaining in solution. To further
demonstrate the utility of the method, we compare the surface coverage of antibody using two
methods of immobilization, direct adsorption and DTSSP coupling chemistry.
Experimental
Materials and Reagents
Gold nanoparticles (AuNPs; 60 nm) were purchased from Ted Pella Inc. (Redding, CA).
Iodine (99.8%, ACS reagent) and potassium iodide were purchased from Fisher Scientific
(Waltham, MA). Borate buffer, goat anti-mouse IgG polyclonal antibody, 3,3’–
dithiobis[sulfosuccinimidylpropionate] (DTSSP), NanoOrange protein quantitation kit, and Zeba
spin desalting columns (7K MWCO, 0.5 mL) were obtained from Thermo Scientific (Rockford,
IL). Gold(III) chloride hydrate (99.999% trace metals basis) was acquired from Sigma Aldrich
(St. Louis, MO). Bio-Rad protein assay dye reagent concentrate was attained from Bio-Rad
Laboratories, Inc. (Hercules, CA). All aqueous solutions were prepared in NANOpure deionized
water (18 MΩ) from a Barnstead water purification system (Thermo Scientific, Rockford, IL).
Antibody-Conjugated Gold Nanoparticles
To directly adsorb antibody onto AuNPs, 1 mL of 60 nm AuNPs was placed into a
microcentrifuge tube, then 40 µL of 50 mM borate buffer (pH 8.5) was added to adjust the pH of
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the solution to 8.5. Then 30 µg of goat anti-mouse IgG was added, and the solution was
incubated at room temperature for > 2 hrs. After incubation the functionalized AuNPs were
centrifuged at 12,500g for 5 min, the supernatant was decanted, and the pelleted nanoparticles
were resuspended in 2 mM borate buffer. The centrifugation/resuspension process was repeated
twice to thoroughly remove excess antibody.
Antibody was also immobilized onto AuNPs via DTSSP, a bifunctional coupling reagent.
To this end, 1 mL of 60 nm AuNPs was placed into a microcentrifuge tube, then 40 µL of 50
mM borate buffer (pH 8.5) was added to adjust the pH of the solution to 8.5, and 10 µL of 5 mM
DTSSP was added to the solution. After incubation at room temperature for 15 min the solution
was centrifuged at 5,000g for 5 min. The supernatant was removed and the pelleted AuNPs were
resuspended in 2 mM borate buffer (pH 8.5). The centrifugation/resuspension steps were
repeated twice to ensure complete removal of excess DTSSP. To the DTSSP-modified AuNP, 30
µg of goat anti-mouse IgG was added and allowed to incubate at room temperature for > 4 hrs.
The functionalized AuNPs were then centrifuged at 12,500g for 5 min and the pelleted AuNP
resuspended in 2 mM borate buffer three times.
Dissolution of Gold Nanoparticles
AuNPs (1 mL) were dissolved by adding 50 µL of a KI/I2 solution consisting of 333 mM
KI and 50 mM I2. This mixture was allowed to react for 15 min to ensure full dissolution of the
AuNPs. Flame atomic absorption spectrophotometry was used to confirm the AuNPs were
completely dissolved.
Direct Determination of Antibody Surface Concentration
NanoOrange reagent was prepared according to the manufacturer’s protocol. Antibody
functionalized AuNPs were centrifuged at 12,500g for 5 min, the supernatant was discarded and
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50 µL of KI/I2 solution was added according to the above procedure to dissolve the AuNPs.
Standard solutions of goat anti-mouse IgG were prepared with appropriate steps to match the
matrix of the samples. To prepare the standard solutions, 1 mL 60 nm AuNPs were centrifuged at
12,500g for 5 min, the supernatant was discarded, KI/I2 was added to the sedimented AuNP
pellet, and the appropriate amount of antibody was then added to each standard. Desalting
columns were used to remove the KI/I2 solution before using the NanoOrange reagent. The
volume of antibody recovered from the desalting column was measured and NanoOrange reagent
was added to each solution to bring the total volume to 1.5 mL. The samples were incubated for
20 min at 90o C in a water bath and cooled to room temperature in the dark. Fluorescence of the
protein-bound NanoOrange dye was measured and correlated with antibody concentration.
Indirect Determination of Antibody Surface Concentration
Antibody functionalized AuNPs were centrifuged at 12,500g for 5 min and 500 µL of the
supernatant was analyzed using a modified Bradford assay (Bio-Rad protein assay). The
collected supernatant was diluted 1:1 with 2 mM borate buffer (pH 8.5) and 250 µL of the BioRad reagent was added. Standard solutions of antibody (1- 20 µg/mL) were prepared in 2 mM
borate buffer (pH 8.5) and 250 µL of Bio-Rad reagent was added to 1 mL of each standard
solution. The samples and standards were then incubated at room temperature for 15-20 min to
allow the color to develop. Absorption was measured at 595 nm to quantify antibody in the
supernatant. The absolute concentration of antibody adsorbed onto the AuNP was inferred to be
the mass difference between the antibody added to the AuNP and the antibody remaining in the
supernatant.
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Instrumentation
Nanoparticle Tracking Analysis (NTA)
The hydrodynamic diameter of the functionalized AuNPs was measured using a
NanoSight LM10, furnished with a temperature controlled LM14G sample viewing cell
configured with a 532 nm laser (Malvern Instruments Ltd Worcestershire, UK). Tracking of the
AuNPs was performed using a high sensitivity sCMOS camera (Hamamatsu Photonics). Samples
were diluted 100-fold to ~108 NP/mL and then injected with a 1 mL syringe (Becton Dickinson,
NJ) utilizing a Harvard Apparatus Pump 11 Elite single injection syringe pump (Harvard
Bioscience Inc. Holliston, MA). Flow injection rate was set to 15 µL/min. Sample analysis was
performed using NanoSight 2.3 software. The software was set to live mode with the camera
level set to 6 and the detection threshold at 5. The samples were analyzed until greater than
10,000 completed tracks were acquired, and hydrodynamic diameter was calculated using the
NanoSight 2.3 software.
Flame Atomic Absorption Spectroscopy
The concentration of Au in the dissolved AuNPs was measured using an AAnalyst 200
Atomic Absorption Spectrometer furnished with an Au-Ag hollow cathode lamp (PerkinElmer
Inc. Waltham, MA). Air was used as the oxidant at a flow rate of 12 L/min while acetylene was
used as the fuel with a flow rate of 1.9 L/min. The Au absorption line at 242.80 nm was
measured with a slit set to 2.7 mm x 1.35 mm. Samples were prepared by dissolving 1 mL of 60
nm AuNPs with 50 µL of KI/I2 solution and diluting to 10 mL with nanopure H2O.
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UV-Visible Absorption
UV-Visible absorption was performed using an Agilent 8453 spectrophotometer
equipped with a photodiode array providing a spectral range of 190-1100 nm (Agilent
Technologies Santa Clara, CA). Sample absorption was measured at 595 nm using 2 mM borate
buffer (pH 8.5) as the blank.
Fluorescence
Fluorescence spectra were acquired with a PerkinElmer LS 55 Luminescence
Spectrometer (PerkinElmer Inc. Waltham, MA). Samples were excited at 485 nm and emission
was measured at 590 nm, as recommended by the manufacturer’s protocol for NanoOrange.
Spectra were collected with 5 s integrations and the excitation/emission slit widths were
maximized (15 nm/20 nm) to maximize the signal-to-noise ratio.
Results and Discussion
Indirect Quantitation of Immobilized Antibody
It is well-established that antibodies self-assemble onto the surface of AuNPs. Protein
adsorption arises from a combination of electrostatic and hydrophobic interactions and is
influenced by many parameters, including pH, ionic strength, and antibody pI.58-60 Based on
previously optimized conjugation conditions, antibody-modified gold nanoparticles were
prepared by adding 30 µg of goat anti-mouse IgG antibody to AuNPs.7 NTA was performed on
the unconjugated and antibody-modified AuNPs in order to confirm adsorption of antibody onto
the AuNPs and the size distributions are shown in Figure 8. From the representative histograms
in Figure 8, the unconjugated AuNPs had a mean hydrodynamic diameter of 62 nm while the
modified AuNPs had a mean hydrodynamic diameter of 78 nm. The histograms shown in Figure
8 illustrate uniform size distributions of the NPs consistent with a monodisperse population.
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Figure 8. Size distribution of AuNP and antibody-modified AuNP measured with NTA.
Greater than 10,000 particles were tracked to create each of the histograms.

NTA analysis of four additional preparations of unconjugated and antibody-modified
AuNP produced similar histograms with a standard deviation of ±0.6 nm in the mean diameter.
The 16 nm shift in the mean diameter of the AuNPs upon conjugation of the antibody is
consistent with other reports for nanoparticles fully saturated with protein.7,47,50,51 The size of an
IgG molecule has been previously reported as 4-10 nm depending on orientation;7,49,61,62 and the
16 nm shift in the mean diameter of the AuNPs upon conjugation of the antibody is consistent
with a monomolecular layer of adsorbed protein, although the possibility of a bilayer exists
depending on antibody orientation. Recent work has demonstrated that protein monolayers form
on nanoparticles,50,63,64 although the possibility for additional proteins to adsorb do exist when
excessively high solution concentrations of protein are used50 or when the pH is near the protein
isoelectric point.65 Based on these previous works and our experimental conditions, we speculate
that a protein monolayer is more likely than a bilayer.
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The quantity of adsorbed protein was indirectly determined by analysis of excess
antibody in the modified AuNP supernatant. A Bio-Rad protein assay was calibrated using
standard solutions of goat anti-mouse IgG antibody (Figure. 9).

Figure 9. Bio-Rad protein assay calibration curve for determining antibody concentration in
AuNP supernatant.

We determined that 25.7 ± 0.6 µg of antibody remained in the supernatant based on the analysis
of supernatant from nine independent preparations of antibody-modified AuNP. It is inferred that
4.3 ± 0.6 µg of antibody adsorbed onto the AuNPs from the mass difference relative to the 30 µg
of antibody added to the AuNPs. This mass corresponds to the adsorption of 660 ± 87 antibodies
per AuNP. A conservative estimate of theoretical monolayer surface coverage is calculated to be
314 antibodies per AuNP based on the total surface area of the AuNPs (2.6 x 1010 NP/mL at 62
nm) and assuming a 7 nm circle as the projected footprint of an antibody. Therefore, this method
of quantifying antibody loading suggests multilayers of protein adsorbed onto the AuNP. This
result, however, contradicts the speculation that a monolayer forms based on the NTA results
(Figure 8) and previous works7,47,50,51 as discussed above.
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We hypothesized that loss of antibody due to adsorption to the centrifuge tube during
AuNP modification would decrease the concentration of antibody in the supernatant and result in
an overestimation of antibody adsorbed onto the AuNP. To test this hypothesis, 30 µg of
antibody was added to 1 mL of 2 mM borate buffer (pH 8.5) in a microcentrifuge tube. The
solution was incubated for 2 hours at room temperature and centrifuged, the same conditions
used for AuNP modification. The protein solution was then analysed with the Bio-Rad protein
assay and 27.5 ± 0.3 µg of protein were recovered, based on three independent analyses, which
suggested that 2.5 ± 0.3 µg were adsorbed onto the surface of the centrifuge tube. Accounting for
the loss of antibody adsorbed onto the centrifuge tube, we can estimate that only 1.8 µg of the
4.3 µg mass difference determined above was due to adsorption onto AuNP. This adsorbed mass
corresponds to a surface coverage of 280 antibodies per AuNP, which further supports our claim
of monolayer coverage.
These studies established that the common method of quantifying antibody adsorbed onto
AuNPs by mass difference leads to an overestimation of the surface coverage. While we show it
may be possible to understand the source of and correct for this systematic bias, these corrective
procedures will increase the uncertainty in the measured values. It is clear that an improved
analytical method that directly measures the adsorbed antibodies is needed.
Dissolution of gold nanoparticles
The dissolution of AuNPs is central for the direct analysis of antibodies adsorbed to the
surface of the AuNP. To this end AuNPs were dissolved by adding a well-established iodineiodide etchant solution to dissolve 1 mL of 60 nm AuNPs. The Au is dissolved by the oxidant
(I3-) which is formed through the reaction of I2 and I-.66
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Flame atomic adsorption spectroscopy was used to confirm that the AuNPs were fully
dissolved by the KI/I2 etchant solution. A calibration curve for the quantitation of Au was
constructed using standard solutions prepared from gold (III) chloride (Figure 10).

Figure 10. Flame atomic absorption spectroscopy calibration curve for determining gold
concentration.

A 1 mL sample of AuNPs was centrifuged and the supernatant was analysed for Au. Figure 11
shows that no gold was detected in the supernatant which confirms that all of the AuNPs were
pelleted upon centrifugation and that the gold ions used to synthesize the AuNPs were fully
reduced during preparation. The pelleted AuNPs were then dissolved with the addition of 50 µL
of KI/I2, and 51.1 ± 0.4 µg of gold were measured in this sample with flame AA (Figure 11).
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Figure 11. Concentration of gold in 1 mL samples measured with flame atomic
absorption spectroscopy. The concentrations are calculated from the average of three
measurements and the error bars represent the standard deviation. (N. D. = not detected).

The theoretical value of Au in 1 mL of AuNPs is 51 µg calculated using the concentration
provided by the manufacture (2.6 × 1010 NP/mL) and the hydrodynamic diameter of the
unconjugated AuNPs measured by NTA (Figure 8). The statistically equivalent values for the
experimental and theoretical amounts of gold suggest that the AuNPs were fully dissolved. To
further verify complete dissolution of the AuNP, the KI/I2 treated AuNPs, i.e., dissolved AuNPs,
were centrifuged to form a pellet of any remaining AuNPs on the bottom of the centrifuge tube.
Although no pellet was visible, the “supernatant” was analysed and determined to contain 50.2 ±
0.8 µg of gold (Figure 11). Given that the amount of gold did not significantly decrease as a
result of centrifugation after KI/I2 treatment, it was concluded that the AuNPs were fully
dissolved.
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Direct Quantitation of Immobilized Antibody
The AuNP core of the antibody-modified AuNP was fully dissolved as described above
for the direct analysis of adsorbed antibodies, and a fluorescent dye, NanoOrange, was used to
label the free protein for quantitation. However, when used in the solution that contains KI/I2
there is interference with the fluorophore resulting in no detectable fluorescence. To circumvent
this issue, a spin desalting column was used to remove excess KI/I2. After desalting, the isolated
antibody was labelled with the fluorescent dye for quantitation.
In order to build an accurate calibration curve, the standard solutions were prepared in the
same matrix as the sample and passed through a desalting column. These standards were
prepared by centrifuging 1 mL of 60 nm AuNPs and dissolving the pellet with the KI/I2 solution
identical to the samples. Varying amounts of antibody were added to each solution and then the
solution was passed through a desalting column to remove any salts that interfere with the
interaction between NanoOrange and the antibody. The calibration curve for the NanoOrangebased assay is shown in Figure 12.

Figure 12. Calibration curve for the NanoOrange-based fluorescence detection of antibody. The
samples were excited at 485 nm and the emission was measured at 590 nm. R2 = 0.9925.
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Direct analysis of antibody isolated, i.e., dissolved with KI/I2 and desalted, from
antibody-modified AuNP with the fluorescence assay measured a surface coverage of 309 ± 93
antibodies per AuNP based on nine independent sample preparations (Figure 13). This is in
contrast to the indirect method based on mass difference between added and excess antibody
described above, which estimated 660 ± 87 antibodies per AuNP (Figure 13).

Figure 13. The absolute surface coverage of antibodies adsorbed onto a 60 nm AuNP
measured with the fluorescence-based NanoOrange assay of the antibodies isolated from the
AuNP (direct quantitation) and the Bio-Rad-based assay of excess unbound antibodies in the
AuNP supernatant (indirect quantitation). Each bar represents the average surface coverage
determined from nine independent preparations of modified AuNP and the error bars represent
the standard deviation.

A t-test was performed to compare the direct and indirect methods of quantifying immobilized
protein, and it was concluded with 99 % confidence that the surface coverages calculated with
the two assays are significantly different. Notably, the surface coverage measured with this novel
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fluorescence-based protocol is more consistent with both the NTA data that indicated a
monolayer of adsorbed protein and the theoretical surface coverage of a protein monolayer.
To further validate the capability of this method to directly quantify immobilized
antibodies, AuNPs were incubated with varying amounts of antibody. NTA was performed to
characterize the antibody adsorption isotherm (Figure 14, Figure 15).

Figure 14. Nanoparticle size distribution curves for AuNP modified with varying amounts of
antibody measured with NTA.

As is evident, the mean hydrodynamic diameter increased from 62 nm for the unconjugated
AuNP to a maximum of 76 nm with increasing amounts of added antibody. Based on the NTA
measured hydrodynamic diameter, the addition of antibody in excess of 10 µg did not result in
increased surface coverage.
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Figure 15. Saturation curves for the adsorption of antibody onto AuNPs. A) Increase in
hydrodynamic diameter measured with NTA. B) Increase in absolute antibody surface coverage
measured with the fluorescence-based method. Two independent analyses were performed to
generate the fluorescence-based data and the average of the two runs was fit to Equation 2.

The antibody adsorption isotherm was also constructed using the absolute quantity of
adsorbed antibody measured with the fluorescence method (Figure 15B). The analysis was
performed twice and the average surface coverage was best fit to a ligand binding model
(Equation 2).
𝑦=

𝐵𝑚𝑎𝑥 𝑥
𝐾𝑑 +𝑥
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(2)

Bmax is the maximum antibody surface coverage at saturation and Kd is the apparent
dissociation constant. Based on the best fit curve, the surface coverage maximized at 323
antibodies per AuNP. This surface coverage is consistent with the value measured for nine
independent preparations with 30 µg antibody (Figure 13) and the theoretical value calculated
from surface area (314 antibodies per AuNP). It is worth noting that the antibody surface
concentration exceeds that of a monolayer for the two highest antibody concentrations for the
second analysis (Figure 15B). While these measured values are not statistically different than
monolayer coverage based on the precision of the fluorescence-based method, it is not possible
to rule out the possibility of additional antibody molecules adsorbing to begin forming a
multilayer when large concentrations of excess antibody are used.50 These results further validate
the fluorescence-based method and demonstrate that the method can be used to quantify subsaturation coverages.
Effect of Coupling Chemistry on Immobilized Antibody
To explore the scope of this analytical method, we quantified antibody coupled to AuNPs
through a bifunctional crosslinker, DTSSP.67,68 A self-assembled monolayer was first formed on
the AuNP surface through cleavage of the disulphide bond and formation of a gold-thiolate bond.
Antibody was then added and primary amines from lysine residues reacted with the terminal
succinimidyl ester to covalently immobilize the antibody through the formation of an amide
bond. A recently published study suggests that DTSSP coupling chemistry is inefficient.21 A
detailed investigation of reaction kinetics determined that heterogeneous hydrolysis of the
succinimidyl ester is three orders of magnitude greater than that of the heterogeneous aminolysis
rate.21 Thus, it is important to determine the effect of DTSSP coupling chemistry on antibody
loading.
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The DTSSP/antibody functionalized AuNPs were dissolved in KI/I2 solution, desalted,
and the isolated protein was quantified with NanoOrange. A total of 1.9 ± 0.3 µg were recovered
from the surface of the functionalized AuNPs (N = 3 independent preparations), which
corresponds to the coupling of 298 ± 46 antibodies per AuNP. Thus, the surface coverage of
antibody immobilized via DTSSP did not significantly differ from the surface coverage obtained
via direct adsorption of antibody to the AuNP (309 ± 94 antibodies per AuNP). Hydrolysis of the
DTSSP-modified AuNP results in surface-bound carboxylates giving the AuNPs a negative
surface charge similar to that of the unconjugated citrate-capped AuNPs. Consequently, it is
likely that antibodies experience similar interactions with unconjugated and DTSSP-modified
AuNPs which have hydrolyzed. Therefore, it is reasonable that both methods, direct adsorption
and DTSSP coupling chemistry, resulted in similar antibody surface coverages.
Conclusions
We have developed a fluorescence-based method to directly quantify antibody adsorbed
onto AuNPs. The method involves a three-step procedure, including dissolution of the AuNPs
with KI/I2, isolation of adsorbed antibody via spin desalting columns, and protein quantification
with NanoOrange, a fluorescent dye. Previous works to evaluate antibody adsorption onto AuNP
are limited in that they indirectly infer the quantity of adsorbed antibody based on analysis of
excess protein in solution or because they only provide a relative surface coverage. The novelty
of this approach is that it directly analyses the antibodies adsorbed onto the AuNP and provides
an absolute measurement of quantity.
To validate the method, we have quantified goat anti-mouse IgG antibody directly
adsorbed onto AuNPs. We determined an absolute surface coverage of 309 ± 94 antibodies per
60 nm AuNP. Moreover, we demonstrate that this novel method is more accurate than estimates
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of absolute surface coverage based on mass difference between the added antibody and excess
antibody remaining in solution after modification.
We anticipate that this method will be broadly applicable to enhancing applications
utilizing protein-modified AuNP, and is not limited to antibody-modified AuNP. NanoOrange is
sensitive to a range of targets, including large peptides, small proteins, and large proteins, such
as IgG.56 The most significant impact of this work, however, may be on the evaluation and
comparison of novel conjugation chemistries aimed at protein orientation. It is well-accepted that
the performance of technologies based on protein-modified nanoparticle is dependent upon both
protein loading and protein orientation to maximize bioactivity. Therefore, it is necessary to
quantify immobilized protein in any novel conjugation chemistry to ensure that enhanced
performance is due to orientation rather than an increase in protein surface coverages.
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CHAPTER III
CHEMICAL MODIFICATION OF ANTIBODY ENABLES PH INDEPENDENT
FORMATION OF STABLE ANTIBODY-GOLD NANOPARTICLE CONJUGATES
Introduction
Protein modification of nanoparticles is essential to new and emerging biosensing
technologies.1-3,69 Antibody-gold nanoparticle conjugates are commonly used for novel
biosensors due to their high specificity and broad applicability.70-72 The sensitivity and stability
of these biosensors is determined by the protein orientation and surface coverage on the gold
nanoparticle, which are governed by the conjugation process of protein onto the gold
nanoparticle surface.36,73,74 An ideal immobilization method would ensure antibody conjugation
and reliability for assay reproducibility and performance. This method would also need to ensure
stabilization of the protein-nanoparticle conjugate in a variety of conditions without hindering
assay performance. While there are several techniques to attach proteins onto gold nanoparticles,
most simple techniques are dependent on the pH of the antibody.6,11,73,74 This presents a
challenge for the development of novel multiplexed assays in which multiple antibodynanoparticle conjugates must be prepared and coexist in a single reagent suspension. Additional
considerations include reversible immobilization and protein orientation on the surface of the
gold nanoparticle.74-77
Immobilization of protein onto gold nanoparticles can occur through direct adsorption or
use of a coupling agent for covalent attachment. Non-covalent direct adsorption is limited in that
the attachment requires a unique and specific pH for each protein. It is well-established that for
optimal adsorption the solution pH must be slightly higher than the isoelectric point (pI) of the
protein.18,24,65 Moreover, direct adsorption does not allow control over orientation of the
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immobilized protein which can adversely affect protein biofunctionality, and it has been argued
that non-covalent attachment allows for desorption which can result in short shelf-life and
unwanted protein exchange.18,74 However, it should be noted that we have not observed protein
desorption or exchange from stable protein-gold nanoparticle conjugates that rely on direct
adsorption for conjugate formation.78
To circumvent the concerns and challenges of direct adsorption, numerous approaches
have been explored to immobilize protein onto gold nanoparticles through covalent coupling
chemistry.79-84 Carbohydrates if present on the protein can be used for attachment; however,
along with being time intensive this method requires carbohydrates to be present on the protein
and is labor intensive.19
Covalent modification of gold nanoparticles using bifunctional crosslinking chemistry
molecules such as DTSSP (3,3'-dithiobis(sulfosuccinimidyl propionate)) is one of the most
widely used method of attachment.13,85-94 The attachment is said to occur by the sulfur binding to
gold nanoparticles, leaving a terminal NHS (N-hydroxysuccinimide) ester group that attaches to
the protein via the primary amine located on lysine.13,91,93 This method however, requires the
solution pH to be high enough for the lysine groups on the protein to be deprotonated;
furthermore, it has been recently proposed that the hydrolysis of NHS occurs faster than
aminolysis onto the primary amine.21,36 This is because the reaction is limited to diffusion of the
protein onto the NHS functionalized gold nanoparticle.21 While there are several methods of
attaching protein onto nanoparticles, the exact chemistry behind these methods is still relatively
unknown, and there is also still a need for a fast universal method of attachment that is stable
under a range of conditions.
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In this chapter, we describe a novel approach to attach protein onto gold nanoparticles
that is fast, is compatible with many antibodies, and generates stable conjugates for a wide range
of pH values. To achieve this, we first modified the lysine residues on the protein with NHSactivated esters, DTSSP or NHS-acrylic acid, to alter the protein charge. The modified protein
was then adsorbed onto the gold nanoparticles to form stable conjugates in high ionic strength
suspensions independent of pH. We determined that this method can be utilized on a range of
antibodies by forming stable conjugates with goat anti-mouse IgG, mouse anti-rabbit IgG, and
rabbit anti-mouse IgG. Furthermore, we demonstrated that the modified antibody maintains
bioactivity towards it target antigen in a functional assay.
Experimental
Materials
Gold nanoparticles (AuNPs; 60 nm) were purchased from Ted Pella Inc. (Redding, CA).
Borate buffer, goat anti-mouse IgG polyclonal antibody, mouse anti-rabbit IgG polyclonal
antibody, rabbit anti-mouse IgG polyclonal antibody, 3,3′-dithiobis[sulfosuccinimidylpropionate]
(DTSSP), and Zeba spin desalting columns (7K MWCO, 0.5 mL) were acquired from Thermo
Scientific (Rockford, IL). Acrylic acid N-hydroxysuccinimide ester (acrylic NHS), and Bovine
serum albumin (BSA) were purchased from Sigma-Aldrich (St Louis, MO). K2HPO4 was
purchased from Mallinckrodt Chemical Inc. (Paris, KT). KH2PO4 was purchased from Fisher
Scientific (Waltham, MA). All aqueous solutions were prepared in NANOpure deionized water
(18 MΩ) from a Barnstead water purification system (Thermo Scientific, Rockford, IL).
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Antibody-NHS Modification
Five µL of NHS linker molecule (Acrylic acid NHS) or DTSSP at the desired
concentration were added to 30 µg of selected antibody and incubated for 2 hrs. Desalting
columns were used to separate the excess linker molecule from the modified antibody. To empty
the stacking buffer, the column was centrifuged at 3000g for 3 min, sample was loaded and 10
µL of 2 mM borate buffer (pH 8.5) was added then the column was centrifuged at 3000g for 4
min. The modified antibody concentration was measured using a NanoDrop 2000c
spectrophotometer (Thermo Scientific, Rockford, IL).
Protein Modified Gold Nanoparticles (pAuNPs)
Direct
One hundred µL of 60 nm AuNPs were placed into a microcentrifuge tube, then 4 µL of
50 mM phosphate buffer solution (pH 6.0, 6.5, 7.0, or 7.5) or 50 mM borate buffer (pH 8.0 or
8.5) were added to adjust the solution to the desired pH. Three µg of desired IgG protein (goat
anti-mouse, mouse anti-rabbit, or rabbit anti-mouse) were then added to each solution and
incubated for 20 min at room temperature. Next 10 µL of 10 % (wt/v) NaCl were added and
dynamic light scattering was used to evaluate the stability of the pAuNPs.
DTSSP-Au
One hundred µL of 60 nm AuNPs were placed into a microcentrifuge tube, then 4 µL of
of 50 mM phosphate buffer solution (pH 6.0, 6.5, 7.0, or 7.5) or 50 mM borate buffer (pH 8.0 or
8.5) were added to adjust the solution to the chosen pH. One µL of 0.5 mM DTSSP was added
and incubated for 1 hour at room temperature. The solution was then centrifuged at 5000g for 5
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min, the pelleted AuNPs were resuspended in 100 µL of 2 mM buffer solution at the desired pH.
The centrifugation/resuspension processes were repeated twice to thoroughly remove excess
unbound DTSSP. Three µg of IgG protein (goat anti-mouse, mouse anti-rabbit, or rabbit antimouse) were then added to the tube and incubated for 20 min, then 10 µL of 10 % (wt/v) NaCl
were added, and dynamic light scattering was used to check the stability.
NHS-Antibody
One hundred µL AuNPs were placed into a mircocentrifuge tube, then 4 µL 5 of 50 mM
phosphate buffer solution (pH 6.0, 6.5, 7.0, or 7.5) or 50 mM borate buffer (pH 8.0 or 8.5) were
added to adjust the solution to the desired pH. Three µg of NHS modified IgG protein (goat antimouse, mouse anti-rabbit, or rabbit anti-mouse) were then added to each solution and incubated
for 20 min at room temperature. Next, 10 µL 10% (wt/v) NaCl were added and dynamic light
scattering was used to check stability of the AuNPs.
Protein Modified AuNP Immunoassay
Direct
One hundred µL of 60 nm AuNPs were placed into a microcentrifuge tube, then 4 µL of
50 mM borate buffer (pH 8.5) was added to adjust the solution to the desired pH. Three µg of
goat anti-mouse IgG were inserted, and the solution was incubated overnight. Following
incubation, the functionalized AuNPs were centrifuged at 5000g for 5 min, the supernatant was
removed, and the pelleted nanoparticles were resuspended in 100 µL of 2 mM borate buffer (pH
8.5). The centrifugation/resuspension processes were repeated twice to thoroughly remove
excess unbound antibody. After the final centrifugation the pelleted nanoparticles were
resuspended into 100 µL of 1% (wt/v) BSA solution. Ten µL of 10% (wt/v) NaCl solution were
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added to determine stability of the pAuNPs. Dynamic light scattering was collected to determine
the hydrodynamic diameter of the modified nanoparticles.
NHS-Antibody
One hundred µL of 60nm AuNPs were placed into a microcentrifuge tube, then 4 µL of
50 mM buffer solution (pH 6.0-8.5) was added to adjust the solution to the desired pH. Three µg
of acrylic (NHS) modified goat anti-mouse IgG were added to the solution and incubated
overnight. The solution was then centrifuged at 5000g for 5 min and resuspended in 100 µL of 2
mM buffer solution at the desired pH. The centrifugation/resuspension process was repeated
twice with the final resuspension being in 100 µL of 1% (wt/v) BSA solution. Ten µL of 10%
(wt/v) NaCl were added to check stability of the pAuNPs, and dynamic light scattering was
collected to determine hydrodynamic diameter of the particles.
Instrumentation
Dynamic Light Scattering
A BI-90Plus (Brookhaven Instruments Corporation, NY) armed with a 658 nm laser and
an avalanche photodiode detector was used. The collection angle of the backscattered light was
90o. Each hydrodynamic diameter reported was the mean of three 30 s runs. The resultant data
were analyzed using the MAS OPTION software.
UV-Visible absorption
A NanoDrop 2000c (Thermo Scientific, Rockford, IL), equipped with a xenon lamp was
used for absorbance measurements. One µL of sample was added to the stage with an
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illumination time of 5 s, the collection wavelength for quantification was set to 280 nm, and the
concentration was calculated by the NanoDrop 2000/2000c software.
Results and Discussion
Immobilization Methods
Immobilization of antibodies onto the surface of gold nanoparticles is commonly
performed via direct adsorption or NHS coupling chemistry. It is well established that antibodies
directly adsorb onto gold nanoparticles (Figure 16A). While the mechanism is not fully
understood, it is known that direct adsorption requires the pH to be slightly basic of the
isoelectric point (pI) of the protein, and occurs through a combination of hydrophobic and
electrostatic interactions.18,24 To demonstrate this, goat anti-mouse IgG was incubated with 60
nm AuNPs in a pH range of 6.0-8.5 in increments of 0.5 pH units. At pH 6.0-7.5, the
nanoparticles aggregated upon addition of the antibody within 5 min as indicated by a color
change of the suspensions observed with the naked eye (Figure 17A).
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Figure 16. Schematic of the types of immobilization methods. A) Direct adsorption. B) DTSSP
functionalized gold nanoparticles followed by antibody adsorption. C) DTSSP modified antibody
followed by adsorption onto gold nanoparticles. D) Acrylic acid (NHS) modified antibody
followed by adsorption onto gold nanoaprticles.

This suggests that at the lower pH values, the protein was sufficiently protonated and carried
sufficient positive charge that it caused the gold nanoparticles to aggregate rather than form a
stable protein-gold nanoparticle conjugate. At pH ≥ 8.0, the AuNP remained red after the
addition of antibody; however, this does not confirm that antibody adsorbed onto the AuNP.
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Figure 17. Goat anti-mouse IgG functionalized gold nanoparticles by direct adsorption and by
DTSSP functionalized gold nanoparticles before the addition of antibody. Both at a pH range of
6.0-8.5 from left to right. A) Before the addition of NaCl. B) After the addition of NaCl to a final
concentration of 1 % (wt/v).

A coagulation test was used to assess adsorption of antibody onto the AuNP to form a stable
conjugate.24 Sodium chloride was added to the antibody-AuNP suspension and dynamic light
scattering (DLS) was used to measure the hydrodynamic diameter (DH) of the modified AuNPs.
A stable conjugate has a DH of ~85-90 nm, consistent with the size of an IgG adlayer, while
unconjugated AuNP will undergo aggregation to form larger assemblies in the presence of
electrolyte.6 Direct adsorption of antibody onto AuNP at pH 8.0 and 8.5 form conjugates with a
DH of 86.9 nm and 89.2 nm after the addition of NaCl, respectively, and are consistent with other
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reported data for stable AuNP-antibody conjugates (Figure 18, Table 1). Goat anti-mouse IgG
has a pI range of 6.5-9.5;95 thus, these data are consistent with other works demonstrating that
the pI or charge of the protein plays a direct role in the adsorption of protein onto gold
nanoparticles.

Figure 18. DLS of antibody functionalized gold nanoparticles after the addition of NaCl. Goat
anti-mouse IgG immobilized using direct adsorption, DTSSP functionalized AuNPs, DTSSP
modified antibody, or acrylic acid (NHS) modified antibody.

It has long been suggested that covalent coupling of antibody to AuNP with
heterobifunctional cross-linker such as 3,3'-dithiobis(sulfosuccinimidyl propionate) (DTSSP)
results in a more stable and robust conjugation that prevents desorption (Figure 16B).13 This
chemistry requires basic conditions to deprotonate lysine residues thereby enabling aminolysis.
A recent study demonstrated that hydrolysis of DTSSP on the AuNP surface occurs faster than
aminolysis.21 Thus, the DTSSP-modified AuNP hydrolyzes to present a terminal carboxylate on
the surface of the AuNP, yielding a similar surface charge as the original citrate capped AuNP. If
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this is the case, immobilization of the antibody to DTSSP-modified AuNP should be similar to
direct adsorption to citrate-capped AuNP and show the same pH dependence. To this end,
DTSSP was attached to AuNPs prepared in buffers ranging from pH 6.0-8.5, excess DTSSP was
removed via centrifugation of the DTSSP-AuNP conjugates, and goat anti-mouse IgG was added
to each solution. At pH 6.0-7.5, the nanoparticles aggregated upon addition of the antibody
within 5 min as indicated by a color change of the suspensions observed with the naked eye
(Figure S4A). At pH ≥ 8.0, the AuNP remained red after the addition of antibody, and a saltinduced coagulation test was performed to confirm immobilization of the antibody onto the
AuNP. DLS measured a DH of 119.3 nm and 119.6 nm at pH 8.0 and 8.5, respectively, indicating
the formation of moderately stable conjugates. Collectively, similar pH dependent trends were
observed for the immobilization of antibody onto citrate-capped and DTSSP-modified AuNP.
These results suggest that the DTSSP adlayer hydrolyzed and the antibody is not covalently
attached to the AuNP through DTSSP to form a conjugate, rather the antibody attached through a
direct adsorption mechanism similar to that of the citrate capped AuNP.
Table 1. Stability of goat anti-mouse IgG in 1 % (wt/v) NaCl solution using the varying
conjugation techniques over a pH range of 6-8.5. pH vs hydrodynamic diameter measured with
DLS.
Hydrodynamic Diameter (nm)

pH
6
6.5
7
7.5
8
8.5

Direct
617.9
722.5
664.5
261.6
86.9
89.2

DTSSP-Au
663.7
385.7
412.9
139.5
119.3
119.6

0.5 mM
DTSSP
82
82
78.6
76.9
76.7
76.2

1 mM
DTSSP
79.5
79
78.1
78.1
77.6
78.1
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5 mM
DTSSP
153.8
190.4
254.6
226.6
597.2
681.3

0.5 mM
Acrylic
acid (NHS)
83.2
79.8
77.8
79.4
77.2
76.6

5 mM
Acrylic
acid (NHS)
74.9
75.9
73.5
69.1
71.4
71.6

We hypothesized that addition of free DTSSP, i.e., not assembled on AuNP, directly to
antibody would result in chemical coupling between the DTSSP and antibody. Free DTSSP is
not limited to the surface of the AuNP and can be prepared at a higher concentration to drive
aminolysis rather than hydrolysis of the DTSSP. The DTSSP modified antibody can then
chemisorb onto the AuNP in a second step via self-assembly through the disulfide moiety to
form a robust conjugate. Moreover, the DTSSP modification would eliminate the positive charge
of protonated lysine that that is responsible for AuNP aggregation at pH values of 6.0-7.5 as
demonstrated above. To test this hypothesis, 0.5 mM DTSSP was incubated with goat antimouse IgG, and the excess DTSSP was removed via size exclusion desalting column. (Figure
16C) The purified DTSSP-antibody conjugate was then added to 60 nm gold nanoparticles at
various pH values (6.0-8.5). Notably, no visual aggregation was observed upon addition to the
AuNP at any pH; this is in contrast to the aggregation induced by the addition of unmodified
antibody to AuNP at low pH values detailed above (Figure 19A). This observation is strong
evidence that DTSSP reacted with the antibody to alter its interaction with AuNP.
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Figure 19. Goat anti-mouse IgG modified with 0.5 mM DTSSP conjugated onto 60 nm gold
nanoparticles. Conjugated at pH values 6.0-8.5 from left to right followed by direct adsorption at
pH 8.5. A) Before the addition of NaCl. B) After the addition of NaCl to a final concentration of
1 % (wt/v).

A coagulation test was conducted to assess immobilization of the DTSSP-modified antibody
onto the AuNP to for a stable conjugate. Upon addition of NaCl to each suspension the
hydrodynamic diameter was measured via DLS and ranged between 76.2 nm to 82.0 nm for the
entire pH range (Figure 18, Table 1). These data confirm that DTSSP chemically modified the
antibody and the modified antibody is immobilized onto the AuNP, independent of pH, to form a
stable conjugate. Furthermore, it was inferred that the adsorption process of the DTSSP modified
protein onto gold nanoparticles was driven by the disulfide functionality imparted by the DTSSP.
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Acrylic Acid (NHS)
In order to confirm that the sulfur from DTSSP was in fact driving the adsorption process
onto gold nanoparticles as hypothesized, the antibody was modified with NHS-acrylic acid rather
than DTSSP. Similar to DTSSP, the NHS-acrylic acid couples to the antibody by means of the
N-hydroxysuccinimidyl ester group via aminolysis with lysine; however, unlike DTSSP, the
acrylic acid does not provide any linking chemistry such as a disulfide for chemisorption to the
AuNP. Therefore, it was anticipated that the formation of a stable conjugate with the NHS
acrylic modified antibody would result from direct adsorption and demonstrate a pH dependence.
To confirm this hypothesis, 0.5 mM acrylic acid (NHS) was incubated with goat anti-mouse IgG
and the excess NHS acrylic acid was removed via size exclusion desalting column. The purified
acrylic acid modified antibody was then added to 60 nm gold nanoparticles at various pH values
(6.0-8.5) (Figure 16D). The AuNP remained stable upon addition of the modified antibody at all
pH values tested, similar to the DTSSP modified antibody (Figure 20A), confirming that the
lysine had been neutralized by the NHS-acrylic acid.
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Figure 20. Goat anti-mouse IgG modified with 0.5 mM acrylic (NHS) (top) and by direct
adsorption (bottom) conjugated onto 60 nm gold nanoparticles. Conjugated at pH values 6.0-8.5
from left to right. A) Before the addition of NaCl. B) After the addition of NaCl to a final
concentration of 1 % (wt/v).

A salt-induced coagulation test was performed to evaluate the stability of the conjugates using
DLS to measure the DH (Figure 18, Table 1). Interestingly, the measured DH was between 76.6
nm and 83.2 nm, indicating the formation of stable conjugates at all pH values (6.0-8.5). These
results contradict our hypothesis that the disulfide of DTSSP was responsible for forming stable
conjugates at 6.0 ≤ pH ≥ 7.5. The stability of these conjugates reveals that the NHS acrylic acid
modified antibody must be adsorbing onto AuNPs via direct adsorption, e.g., hydrophilic,
hydrophobic, electrostatic, and native thiols of the cysteine residues. Moreover, these antibody
modifications indicate that antibodies can be immobilized onto AuNP over a wide range of pH
values without bifunctional coupling agents provided that the basic lysine residues are converted
to a chemical moiety such that the charge is no longer pH dependent.
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To establish broad applicability of this conjugation method, AuNP conjugates were
synthesized with mouse anti-rabbit IgG (mIgG) or rabbit anti-mouse IgG (rIgG). For each
antibody, conjugates were prepared using unmodified, DTSSP modified, and acrylic acid
modified antibody at pH values ranging from 6.0 to 8.5. The AuNP were stable after the addition
of unmodified, DTSSP modified, and acrylic acid modified mouse anti-rabbit IgG at all pH
values. Surprisingly, all the prepared mouse anti-rabbit IgG conjugates (unmodified and
modified) were stable upon addition of NaCl at each pH, with a DH ranging from 73 – 95 nm
(Figure 21, Table 2). The stability of the conjugates prepared with unmodified antibody over the
pH range shows that mouse anti-rabbit IgG is less pH dependent than other proteins tested.

Figure 21. DLS of mouse anti-rabbit IgG functionalized gold nanoparticles after the addition of
NaCl. Mouse anti-rabbit IgG immobilized using direct adsorption, DTSSP modified antibody,
and acrylic acid (NHS) modified antibody.
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Table 2. Stability of mouse anti-rabbit IgG in 1 % (wt/v) NaCl solution using the varying
conjugation techniques at a pH range of 6-8.5. pH vs hydrodynamic diameter measured with
DLS.
Hydrodynamic Diameter (nm)

pH
6
6.5
7
7.5
8
8.5

Direct
95
84.3
79.1
79.3
77.7
76.7

0.5 mM
DTSSP
79.3
79.6
77.6
75.4
73.9
75.7

1 mM
DTSSP
80.3
79
80.2
80.8
113.4
120.7

5 mM
DTSSP
151.9
144.4
153.3
281.3
436.5
525

0.5 mM
Acrylic
acid
(NHS)
80.3
80.8
76.9
75.3
75.3
77.5

5 mM
Acrylic
acid
(NHS)
229.9
227
303.8
256
223.1
357.5

Conversely, the unmodified rIgG immediately caused the AuNPs to aggregate at all pH
values prior to the addition of NaCl. Addition of the DTSSP and acrylic acid modified rabbit
anti-mouse IgG did not cause the AuNP to aggregate; however only the DTSSP modified rabbit
anti-mouse IgG at pH 8.0 and 8.5 resulted in a stable conjugate to resist salt induced aggregation
(Figure 22, Table 3).
To further investigate this modification effect, rabbit anti-mouse IgG was modified with
NHS (0.5 mM DTSSP and 0.5 mM acrylic acid (NHS)), and unmodified in the same pH range
(6.0-8.5). Upon the addition of NaCl, DLS was measured and the hydrodynamic diameter for all
samples was well over 100 nm showing aggregation for the modified protein-AuNP conjugates,
and unmodified protein-AuNP conjugates. (Table 3) In an effort to stabilize rabbit anti-mouse
IgG conjugated onto gold nanoparticle, the NHS concentration was varied: 1 mM DTSSP, and 5
mM DTSSP were used in the modification procedure. Upon the addition of NaCl and DLS
measurement, the 1 mM DTSSP aggregated, while 5 mM DTSSP modified rabbit anti-mouse
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IgG was stable in the entire pH range (6.0-8.5) (Figure 22, Table 3). This led us to test the acrylic
acid (NHS) modification at a 5 mM concentration as well (Figure 22). Table 3 shows that the
hydrodynamic diameter for these was also over 100 nm for each sample.

Figure 22. DLS of rabbit anti-mouse IgG functionalized gold nanoparticles after the addition of
NaCl. Rabbit anti-mouse IgG immobilized using direct adsorption, DTSSP modified antibody,
and acrylic acid (NHS) modified antibody.
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Table 3. Stability of rabbit anti-mouse IgG in 1 % (wt/v) NaCl solution using the varying
conjugation techniques at a pH range of 6-8.5. pH vs hydrodynamic diameter measured with
DLS.
Hydrodynamic Diameter (nm)

pH
6
6.5
7
7.5
8
8.5

Direct
688.1
652.8
584.7
619.3
502
508.1

0.5 mM
DTSSP
510.2
486.8
478.1
447.1
457
439.8

1 mM
DTSSP
266.9
274.1
261.3
223.7
204.7
160.8

5 mM
DTSSP
95.5
93.4
84.6
84.8
70.5
71.2

0.5 mM
Acrylic
acid
(NHS)
352.9
398.1
421.4
427.6
454.3
433.2

5 mM
Acrylic
acid
(NHS)
103.8
114.4
129.7
130.1
118.4
104.1

Because it is known that the pI of an antibody is where it has a net neutral charge, and
that the pH for optimal binding via direct adsorption is slightly higher than the pI of the antibody.
We hypothesize that this stabilization at 5 mM DTSSP but instability at 5 mM acrylic acid is due
to the charge on the protein. While both DTSSP and acrylic acid (NHS) react with lysine groups,
DTSSP is changing the charge on the lysine from positive to negative, while acrylic acid (NHS)
is changing it from a positive charge to neutral. The instability at the lower concentrations of
NHS (0.5 mM) suggest that the antibody has not been neutralized enough for optimal binding
onto gold nanoparticles.
This motivated us to test multiple concentrations of DTSSP, and acrylic acid (NHS) for
each antibody used to test our hypothesis. Table 1 shows our full analysis of goat anti-mouse IgG
with multiple concentrations of DTSSP and acrylic acid (NHS). At a concentration of 5 mM, the
DTSSP modification aggregated (well over 100 nm) at all pH values in the 6.0-8.5 range when
introduced to a 1% (wt/v) NaCl solution, however the 5 mM acrylic acid (NHS) was stable
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(between 75 nm and 85 nm) at all pH values in the same environment (Table 1). Upon
performing the same experiment with mouse anti-rabbit IgG, both 5 mM DTSSP and 5 mM
acrylic acid (NHS) modification were aggregated (well over 100 nm) in the entire pH range (6.08.5) (Table 2). With rabbit anti-mouse IgG (Table 3) stability is only fully effective at a 5 mM
concentration of DTSSP. When using 5 mM acrylic acid (NHS), the aggregates measured with
DLS are smaller than that obtained from direct adsorption, but are not completely stable. All
antibodies differ in the amount of lysine groups present, therefore it would be reasonable to
assume that each would require a unique concentration of the NHS modification. When
modifying an antibody with acrylic acid (NHS) the lysine group changes from a positive
terminus, to a neutral charge; however, when modifying with DTSSP, it changes from the
positive to a negative form. Because the stability of the AuNP-antibody conjugates does not
depend on the sulfur group from DTSSP, the stability of these conjugates must be related to the
charge on the surface of the antibody. Since all antibodies differ in the amount of lysine, it would
make sense that each would require a unique concentration of the NHS modification.
Amino Acid Analysis
To further investigate this hypothesis, amino acid analysis was performed on each of the
antibodies used in the experiment. The lysine:IgG ratio was different for each protein studied.
Goat anti-mouse IgG had a ratio of 4.98, while mouse anti-rabbit had a ratio of 4.23, and rabbit
anti-mouse had a ratio of 20.10. These ratios align with the concentration of NHS modification
needed to stabilize the proteins onto AuNPs. Goat anti-mouse IgG (Table 1) having a lysine:IgG
ratio of 4.98, only needed 0.5 mM NHS modification to neutralize the charge. Mouse anti-rabbit
IgG (Table 2) lysine:IgG ratio of 4.23 was stable without modification of NHS and at 0.5 mM
NHS modification. Both the goat (Table 1) and mouse (Table 2) antibodies were not stable at a
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higher concentration of NHS (5.0 mM), this suggest that modifying all the lysine groups has an
adverse effect to the binding ability onto a gold nanoparticle. Rabbit anti-mouse IgG (Table 3)
has a larger lysine:IgG ratio of 20.10 causing it only to be stable when the lysine is changed to a
negative charge with DTSSP at a concentration of 5 mM.
Modified Antibody Functionality
It is reasonable to assume that there are lysine groups on both the Fc and Fab regions of
the IgG molecule; thus, modifying lysine on the Fab region could induce an adverse effect on
binding to the antigen. To determine the viability of the antibody-antigen binding after NHS
modification, we performed an aggregation based assay utilizing DLS.6 Goat anti-mouse IgG
was modified with acrylic acid (NHS), then incubated with 60 nm AuNPs over a pH range of
6.0-8.5. This was compared to a direct adsorption assay with goat anti-mouse IgG on 60 nm
AuNPs at pH 8.5. A typical DLS assay is performed with direct adsorption at pH 8.5,
consequently direct adsorption at pH 8.5 was used to compare to the acrylic acid (NHS) modified
antibody at pH 6.0- 8.5 at a sample concentration range of 0.5 ng/mL to 5000 ng/mL. Acrylic
acid (NHS) was used instead of DTSSP for two reasons; it is cheaper, and it should not bind to
AuNPs when free in solution like DTSSP; it is possible that the spin column step could be
removed making it faster and cheaper. The modification of the antibody lysine groups with NHS
did not stop the aggregation assay from performing as expected at the entire pH range (Figure
23, Table 2), confirming that the antibody modification does not hinder the antibody-antigen
binding.
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Table 4. Hydrodynamic diameter (DH) increase of the DLS assay with acrylic acid (NHS)
modified goat anti-mouse IgG at a pH range of 6.0-8.5, and direct adsorption at pH 8.5
Average Hydrodynamic Diameter Increase (nm)
Acrylic acid (NHS)
Conc
(ng/mL)
5000
500
50
5
0.5
PBS

pH 6.0
18.7
44.7
97.3
35.9
5.9
0.0

pH
6.5
14.4
44.3
94.9
33.4
4.5
0.0

pH 7.0
12.8
47.1
83.4
19.7
3.8
0.0

pH 7.5
13.5
37.9
81.1
19.2
2.3
0.0

Direct
pH 8.0
11.6
46.8
71.9
14.9
0.5
0.0

pH 8.5
11.3
38.1
64.4
12.5
2.2
0.0

pH 8.5
18.2
80.0
143.4
35.7
3.2
0.0

Figure 23. Calibration curve of the DLS immunoassay with goat anti-mouse IgG showing the DH
increase with respect to concentration of IgG. Direct adsorption at pH 8.5 and acrylic acid (NHS)
modified at pH 6.5 and 8.5, as shown the error bars represent the standard deviation of 3
independent assays. The dashed lines represent the limit of detection for each immobilization
method.
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The data in Figure 23 and Table 4 show that when the acrylic acid (NHS) assay is performed at a
lower pH it has larger aggregation. While pH 6.0 had the largest hydrodynamic diameter
increase, pH 6.5 was used because it is close to physiological pH in addition to having large
aggregation. Figure 23 illustrates the hooking effect in the extended calibration curve of the
assay, we wanted to zoom onto the linear range of the assay to compare analytical figures of
merit of the new assay to those of direct adsorption. Figure 24A shows the assay of direct
adsorption and acrylic acid (NHS) modified antibody from 0.1 ng/mL to 50 ng/mL. This assay
also reached a maximum at 10 ng/mL for direct adsorption and 25 ng/mL for acrylic acid (NHS)
modified.
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Figure 24. Calibration curve of goat anti-mouse IgG with direct adsorption at pH 8.5 and acrylic
acid modified at pH 6.5. A) Lower range of the calibration curve, error bars are the standard
deviation of 3 independent assays. B) Trendline of the linear portion of the graph.

The linear portions of each calibration curve were used for linear regression and
analytical figures of merit (Figure 24B). The acrylic acid (NHS) modified antibody DLS assay at
pH 6.5 behaved similar to the direct adsorption DLS assay. Table 5 list the analytical figures of
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merit for each assay demonstrating that the assay is not only viable, but its performance is
comparable to the direct adsorption assay.
Table 5. Figures of merit for the dynamic light scattering immunoassay with goat anti-mouse
IgG comparing direct adsorption at pH 8.5 to acrylic acid (NHS) modified antibody at pH 6.5.

Figures of Merit for Goat Anti-Mouse IgG

Direct pH 8.5

Acrylic (NHS) pH 6.5

Min. det. Signal (nm)

2.16

1.90

LOD (ng/mL)

0.59

0.38

Once the best pH was determined, we wanted to explore the above hypothesis of
modifying antibody with acrylic acid (NHS) and not using a spin column to remove the free
acrylic acid (NHS). To this end goat anti-mouse IgG was incubated with acrylic acid (NHS),
then added to gold nanoparticles without using a spin column to remove the excess acrylic acid
(NHS). Acrylic acid (NHS) modified goat anti-mouse IgG with excess NHS removed via spin
column was performed alongside to control the experiment. As shown in Figure 25, the spin
column is not needed for the assay to function properly and the values are well within error even
when compared to the data in table 4.
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Figure 25. Calibration curve of acrylic acid (NHS) modified goat anti-mouse IgG at pH 6.5 with
and without filtering via a spin column.

Conclusions
We have established that the modification of antibody with bifunctional crosslinking
molecules reduces the overall positive charge of the antibody allowing for direct adsorption onto
gold nanoparticles and stabilization over a range of pH values. We show this method is effective
on multiple antibodies demonstrating broad applicability, which has implications for a broad
impact on novel immunoassay development. When compared, unmodified vs modified antibody
with our dynamic light scattering immunoassay both detection limits were essentially identical
~1.0 ng/mL. This concludes that modification has not affected the active site of the antibody.
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CHAPTER IV
CONCLUSIONS AND FUTURE DIRECTIONS
Research Summary
The results from this investigation lead to several new insights on protein modified gold
nanoparticle immunoassays. The first part of the work focused on the development of a novel
fluorescence based detection method for the direct quantification of antibody immobilized onto
gold nanoparticles. This method focused on dissolving the gold nanoparticle using a KI/I2
etchant solution with the proteins adsorbed onto the surface of the nanoparticle. The gold ions
were filtered out using a size exclusion spin column to obtain the purified antibody. The isolated
antibody was then tagged with NanoOrange a fluorescent dye that is capable of detecting low
concentrations of protein. From this assay we determined 309 ± 93 antibodies adsorb onto a 60
nm gold nanoparticles which is consistent with a fully adsorbed monolayer based on the footprint
of an IgG molecule. We confirmed that multilayers do not form on the surface of a gold
nanoparticle by measuring a hydrodynamic diameter increase from 62 nm unconjugated to 76
nm conjugated. Finally we used a more conventional method of antibody quantification by
supernatant analysis which overestimated the surface coverage at 660 ± 87 antibodies per
nanoparticle demonstrating that our fluorescence based method is a more accurate substitute to
the typical approach.
This fluorescence assay is not only able to detect large proteins such as IgG but also
small proteins and large peptides. Perhaps the most impact this work will have is on the
comparison of new conjugations chemistries towards protein orientations. The performance of
protein modified nanoparticle based sensors is dependent on the number of immobilized proteins
and the orientation to exploit the bioactivity of the protein. Thus, quantification of immobilized
protein is imperative to the performance of new and emerging immobilization techniques based
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on orientation to confirm that higher performance is from orientation not an increase in protein
on the nanoparticle surface.
The second part of this work was to find an immobilization method for antibody onto
gold nanoparticles that is independent of pH. Conventional methods such as direct adsorption or
bifunctional crosslinking chemistry rely on isoelectric point of the antibody of choice. This is
limiting when working with multiple antibodies in the same solution conditions that are needed
for novel gold nanoparticle based immunoassays capable of multiplex detection. To achieve
stable antibody-gold nanoparticle conjugates independent of pH we first modified the antibody
with DTSSP or acrylic acid (NHS); these molecules are known to form an amide bond between
the carboxyl group from the molecules and at terminal amine from lysine. We tested this method
via a coagulation test and performed dynamic light scattering to ensure stable conjugates. We
show broad applicability of the method by testing it with three different antibodies: goat antimouse IgG, rabbit anti-mouse IgG, and mouse anti-rabbit IgG. We found that by modifying the
antibody with DTSSP the positively charged lysine is converted to a negative charge from the
terminal carboxyl upon hydrolysis of the DTSSP molecule after modification. Similarly, when
using acrylic acid (NHS) the lysine transformed from positive to neutral. This has significance
because adsorption of the antibody to gold nanoparticles is based on the isoelectric point of the
antibody and by changing the isoelectric point we can effectively manipulate the antibody to
stabilize under conditions it previously had not been stable. Finally, to ensure the antibody
modification was not hindering the active site of the antibody a dynamic light scattering
immunoassay was performed against the conventional direct adsorption method and it was found
that the detection limit of both assays was ~1.0 ng/mL. This work significantly enhances the
field by providing a novel method of immobilization that is independent of pH. For the
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achievement of multiplex detection of protein based nanosensors, these sensors must have
protein immobilized and stable under the same solution conditions.
Outlook and Future Directions
In the field of nanoscience there are many protein modified gold nanoparticle assays and
sensors. This work provides insights on the protein-gold nanoparticle interface which could be
utilized for many novel nanoparticle based sensors. These nanosensors are important for new
rapid screening techniques utilizing methods such as surface enhanced Raman spectroscopy
(SERS). SERS has low detection limits and multiplexing capabilities which is something the
Driskell lab is working toward. This work has applications in comparing the activity of an
antibody on a surface to the number of antibodies immobilized for determining the number of
active antibodies immobilized on the surface vs inactive, something that should be considered
when developing a new detection method using nanosensors.
Future directions of this work would be the utilization of the immobilization method in
new gold nanoparticle based immunoassays developed in the Driskell lab. A direction the lab is
currently focusing is the use of Fab portions of the antibody. Immobilization with the Fab
portions could lead to a higher density of active sites on the surface of the nanoparticle thus, an
improved assay. Previously our lab used goat anti-mouse Fab fragments and was unable to form
stable Fab-AuNP conjugates. While a 60 nm gold nanoparticle with Fab conjugated onto it
should have a hydrodynamic diameter (DH) around 65-75 nm in a 1 % (wt/v) NaCl solution,
previous efforts using direct adsorption were only able to obtain 147.9 nm DH indicating
aggregation of the Fab-nanoparticle conjugates. Using acrylic acid (NHS) we were able to obtain
stable conjugates with DH from 66.2 nm to 73.2 nm. We performed an assay with the acrylic Fab
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and compared it with our whole acrylic acid (NHS) modified goat anti-mouse IgG assay as
shown in Figure 26.

Figure 26. DLS with mean DH increase vs IgG concentration comparing whole antibody vs Fab
fragment.

The Fab assay proved to have a much greater sensitivity that the whole antibody. This is
promising evidence that this assay could lead to lower limits of detection and perform faster than
previous assays we have developed. We could also co-functionalize the acrylic-Fab antibody
onto AuNPs and possibly perform a solution SERS assay, something that has been a goal of the
Driskell lab group.
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